Nicholas McAndrew MD MSCE
Breast Cancer
Assistant Professor, Division of Hematology/Oncology, University of California Los Angeles
Join to View Full Profile
120 S. Spalding Drive, Suite 401Beverly Hills, CA 90212
Phone+1 310-205-0771
Fax+1 310-205-0771
Dr. McAndrew is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Perelman School of Medicine at the University of PennsylvaniaMSCE, Clinical Epidemiology, 2016 - 2018
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2015 - 2018- University of Pennsylvania Health SystemResidency, Internal Medicine, 2012 - 2015
Perelman School of Medicine at the University of PennsylvaniaClass of 2012, MD- Villanova UniversityBS, Biology, Manga Cum Laude, 2004 - 2008
Certifications & Licensure
CA State Medical License 2018 - 2025
PA State Medical License 2012 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- Surgical outcomes following neoadjuvant chemotherapy with and without immunotherapy in patients with triple-negative breast cancer.Anouchka Coste Holt, Courtney A Smith, Maurice J Berkowitz, Jennifer L Baker, Nicholas P McAndrew
Discover Oncology. 2024-09-20 - 2 citationsRectal Cancer Survival for Residual Carcinoma In Situ Versus Pathologic Complete Response After Neoadjuvant Therapy.Nathan M Kohrman, Jordan R Wlodarczyk, Li Ding, Nicholas P McAndrew, Sandra D Algaze
Diseases of the Colon and Rectum. 2024-07-01 - 69 citationsRibociclib plus Endocrine Therapy in Early Breast Cancer.Dennis Slamon, Oleg Lipatov, Zbigniew Nowecki, Nicholas McAndrew, Bozena Kukielka-Budny
The New England Journal of Medicine. 2024-03-21
Abstracts/Posters
- Neutropenia and response to single agent palbociclib.Nicholas Patrick McAndrew, Mark Andrew Dickson, Amy Sanders Clark, Andrea Troxel, Christopher Colameco, Maryann Gallagher, Kristi Gramlich, Kelly Zafman, David J. Vaug..., 2018 Annual ASCO Meeting, Chicago, IL, 6/2/2018
- Abstract P4-22-14: Single agent palbociclib with or without trastuzumab for the treatment of Rb+ advanced breast cancerAS Clark, X Wang, A Troxel, J Burrell, M Feldman, P Lal, P Zhang, M Rosen, M Gallagher, J Ndicu, I Nivar, J Matro, SM Domchek, KR Fox, P O'Dwyer and A DeMichele, 2016 San Antonio Breast Cancer Symposium, San Antonio, TX, 12/9/2016
- Oncotype DX scores in BRCA1 and BRCA2 associated breast cancer.Nicholas Patrick McAndrew , Kara Noelle Maxwell , Jill Stopfer , Jacquelyn Powers , Amanda C. Brandt , Jessica M. Long , Katherine L. Nathanson , Susan M. Domchek, 2015 Annual ASCO Meeting, Chicago, IL, 5/30/2015
Authored Content
- CDK4/6 Inhibitors Explored in Adjuvant Breast Cancer SettingJanuary 2019
Press Mentions
SABCS: Improved Survival for Advanced Breast Cancer, Using Genomics to Identify Patients with High Risk of Recurrence, How race/ethnicity Influence the Risk of Heart Failure in Early-Stage Breast Cancer and MoreDecember 5th, 2024- Targeted Therapy for Early Breast Cancer and Advances in PSMA PET Scans at ASCOMay 22nd, 2023
Professional Memberships
- Member
External Links
- UCLA Health Profilehttps://www.uclahealth.org/nicholas-mcandrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
